Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc

Bullboard Posts

Comment by Actuarialon May 23, 2017 9:25am

88 Views

Post# 26272120

RE:RE:RE:What do you expect? Useless Female CEO

Spartan8er wrote: Sharecropper1:

As a CEO, it is her job to create value for the shareholders and what she's done here is simply to line her own pockets with their cash.

Exactly! If she failed to deliver results, she is a useless CEO regardless how shining her CV is.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?